Q62799
Gene name |
Erbb3 |
Protein name |
Receptor tyrosine-protein kinase erbB-3 |
Names |
EC 2.7.10.1 , Proto-oncogene-like protein c-ErbB-3 |
Species |
Rattus norvegicus (Rat) |
KEGG Pathway |
rno:29496 |
EC number |
2.7.10.1: Protein-tyrosine kinases |
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
165-303 (Domain II) |
Relief mechanism |
Partner binding, PTM |
Assay |
|
Accessory elements
No accessory elements
References
- Zhang X et al. (2006) "An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor", Cell, 125, 1137-49
- Ferguson KM et al. (2003) "EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization", Molecular cell, 11, 507-17
- Whitson KB et al. (2005) "Functional effects of glycosylation at Asn-579 of the epidermal growth factor receptor", Biochemistry, 44, 14920-31
- Contessa JN et al. (2008) "Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells", Cancer research, 68, 3803-9
- Huang X et al. (2009) "Structural insights into the inhibited states of the Mer receptor tyrosine kinase", Journal of structural biology, 165, 88-96
- Kovacs E et al. (2015) "Analysis of the Role of the C-Terminal Tail in the Regulation of the Epidermal Growth Factor Receptor", Molecular and cellular biology, 35, 3083-102
Autoinhibited structure

Activated structure

1 structures for Q62799
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q62799-F1 | Predicted | AlphaFoldDB |
No variants for Q62799
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
No variants for Q62799 |
No associated diseases with Q62799
No regional properties for Q62799
Type | Name | Position | InterPro Accession |
---|---|---|---|
No domain, repeats, and functional sites for Q62799 |
Functions
Description | ||
---|---|---|
EC Number | 2.7.10.1 | Protein-tyrosine kinases |
Subcellular Localization |
|
|
PANTHER Family | ||
PANTHER Subfamily | ||
PANTHER Protein Class | ||
PANTHER Pathway Category | No pathway information available |
9 GO annotations of cellular component
Name | Definition |
---|---|
apical plasma membrane | The region of the plasma membrane located at the apical end of the cell. |
basal plasma membrane | The region of the plasma membrane located at the basal end of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
basolateral plasma membrane | The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
ERBB3:ERBB2 complex | A heterodimeric complex between the tyrosine kinase receptor ERBB2 and a ligand-activated receptor ERBB3. ERBB2, which does not bind any known ligand, is activated through formation of a heterodimer with another ligand-activated ERBB family member such as ERBB3. |
extracellular space | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
lateral plasma membrane | The portion of the plasma membrane at the lateral side of the cell. In epithelial cells, lateral plasma membranes are on the sides of cells which lie at the interface of adjacent cells. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
postsynaptic membrane | A specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the postsynaptic membrane. |
receptor complex | Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
12 GO annotations of molecular function
Name | Definition |
---|---|
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
ErbB-3 class receptor binding | Binding to the protein-tyrosine kinase receptor ErbB-3/HER3. |
growth factor binding | Binding to a growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate. |
identical protein binding | Binding to an identical protein or proteins. |
neuregulin binding | Binding to a neuregulin, a member of the EGF family of growth factors. |
neuregulin receptor activity | Combining with a neuregulin, a member of the EGF family of growth factors, and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
protein heterodimerization activity | Binding to a nonidentical protein to form a heterodimer. |
protein tyrosine kinase activator activity | Increases the activity of a protein tyrosine kinase, an enzyme which phosphorylates a tyrosyl phenolic group on a protein. |
signaling receptor activity | Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response. |
transmembrane receptor protein tyrosine kinase activity | Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction |
transmembrane signaling receptor activity | Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction. |
ubiquitin protein ligase binding | Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins. |
35 GO annotations of biological process
Name | Definition |
---|---|
axonogenesis | De novo generation of a long process of a neuron, including the terminal branched region. Refers to the morphogenesis or creation of shape or form of the developing axon, which carries efferent (outgoing) action potentials from the cell body towards target cells. |
cellular response to insulin stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. |
circadian rhythm | Any biological process in an organism that recurs with a regularity of approximately 24 hours. |
cranial nerve development | The process whose specific outcome is the progression of the cranial nerves over time, from its formation to the mature structure. The cranial nerves are composed of twelve pairs of nerves that emanate from the nervous tissue of the hindbrain. These nerves are sensory, motor, or mixed in nature, and provide the motor and general sensory innervation of the head, neck and viscera. They mediate vision, hearing, olfaction and taste and carry the parasympathetic innervation of the autonomic ganglia that control visceral functions. |
endocardial cushion development | The progression of a cardiac cushion over time, from its initial formation to the mature structure. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves. |
epidermal growth factor receptor signaling pathway | The series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
ERBB2-ERBB3 signaling pathway | The series of molecular signals initiated by binding of a ligand to a ERBB3 receptor on the surface of a cell, followed by transmission of the signal by a heterodimeric complex of ERBB2 and ERBB3. ERBB2, which does not bind any known ligand, is activated through formation of a heterodimer with another ligand-activated ERBB family member such as ERBB3. ERBB3 also has impaired kinase activity and relies on ERBB2 for activation and signal transmission. |
extrinsic apoptotic signaling pathway in absence of ligand | The series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with withdrawal of a ligand from a cell surface receptor, and ends when the execution phase of apoptosis is triggered. |
mammary gland involution | The tissue remodeling that removes differentiated mammary epithelia during weaning. |
motor neuron apoptotic process | Any apoptotic process in a motor neuron, an efferent neuron that passes from the central nervous system or a ganglion toward or to a muscle and conducts an impulse that causes movement. |
myelination | The process in which myelin sheaths are formed and maintained around neurons. Oligodendrocytes in the brain and spinal cord and Schwann cells in the peripheral nervous system wrap axons with compact layers of their plasma membrane. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier. |
negative regulation of apoptotic process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
negative regulation of cell adhesion | Any process that stops, prevents, or reduces the frequency, rate or extent of cell adhesion. |
negative regulation of motor neuron apoptotic process | Any process that stops, prevents or reduces the frequency, rate or extent of motor neuron apoptotic process. |
negative regulation of neuron apoptotic process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons. |
negative regulation of secretion | Any process that stops, prevents, or reduces the frequency, rate or extent of the controlled release of a substance from a cell or a tissue. |
negative regulation of signal transduction | Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction. |
neurogenesis | Generation of cells within the nervous system. |
neuron apoptotic process | Any apoptotic process in a neuron, the basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system. |
peripheral nervous system development | The process whose specific outcome is the progression of the peripheral nervous system over time, from its formation to the mature structure. The peripheral nervous system is one of the two major divisions of the nervous system. Nerves in the PNS connect the central nervous system (CNS) with sensory organs, other organs, muscles, blood vessels and glands. |
phosphatidylinositol 3-kinase/protein kinase B signal transduction | A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound. |
phosphorylation | The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide. |
positive regulation of calcineurin-NFAT signaling cascade | Any process that activates or increases the frequency, rate or extent of signaling via the calcineurin-NFAT signaling cascade. |
positive regulation of cardiac muscle tissue development | Any process that activates, maintains or increases the frequency, rate or extent of cardiac muscle tissue development. |
positive regulation of cell population proliferation | Any process that activates or increases the rate or extent of cell proliferation. |
positive regulation of gene expression | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
positive regulation of glucose import | Any process that activates or increases the frequency, rate or extent of the import of the hexose monosaccharide glucose into a cell or organelle. |
regulation of cell population proliferation | Any process that modulates the frequency, rate or extent of cell proliferation. |
response to xenobiotic stimulus | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. |
Schwann cell development | The process aimed at the progression of a Schwann cell over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. Schwann cells are found in the peripheral nervous system, where they insulate neurons and axons, and regulate the environment in which neurons function. |
Schwann cell differentiation | The process in which a relatively unspecialized cell acquires the specialized features of a Schwann cell. Schwann cells are found in the peripheral nervous system, where they insulate neurons and axons, and regulate the environment in which neurons function. |
signal transduction | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
skeletal muscle tissue development | The developmental sequence of events leading to the formation of adult skeletal muscle tissue. The main events are |
tongue development | The process whose specific outcome is the progression of the tongue over time, from its formation to the mature structure. The tongue is the movable, muscular organ on the floor of the mouth of most vertebrates, in many other mammals is the principal organ of taste, aids in the prehension of food, in swallowing, and in modifying the voice as in speech. |
transmembrane receptor protein tyrosine kinase signaling pathway | The series of molecular signals initiated by an extracellular ligand binding to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with the regulation of a downstream cellular process, e.g. transcription. |
33 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
P13387 | EGFR | Epidermal growth factor receptor | Gallus gallus (Chicken) | SS |
P04626 | ERBB2 | Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (Human) | SS |
P00533 | EGFR | Epidermal growth factor receptor | Homo sapiens (Human) | EV |
Q15303 | ERBB4 | Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (Human) | SS |
P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (Human) | SS |
Q01279 | Egfr | Epidermal growth factor receptor | Mus musculus (Mouse) | SS |
P70424 | Erbb2 | Receptor tyrosine-protein kinase erbB-2 | Mus musculus (Mouse) | SS |
Q61527 | Erbb4 | Receptor tyrosine-protein kinase erbB-4 | Mus musculus (Mouse) | SS |
Q61526 | Erbb3 | Receptor tyrosine-protein kinase erbB-3 | Mus musculus (Mouse) | SS |
G3V9H8 | Ret | Proto-oncogene tyrosine-protein kinase receptor Ret | Rattus norvegicus (Rat) | SS |
Q62838 | Musk | Muscle, skeletal receptor tyrosine protein kinase | Rattus norvegicus (Rat) | SS |
Q63604 | Ntrk2 | BDNF/NT-3 growth factors receptor | Rattus norvegicus (Rat) | SS |
P35739 | Ntrk1 | High affinity nerve growth factor receptor | Rattus norvegicus (Rat) | SS |
Q03351 | Ntrk3 | NT-3 growth factor receptor | Rattus norvegicus (Rat) | SS |
Q91ZT1 | Flt4 | Vascular endothelial growth factor receptor 3 | Rattus norvegicus (Rat) | SS |
O08775 | Kdr | Vascular endothelial growth factor receptor 2 | Rattus norvegicus (Rat) | SS |
Q64716 | Insrr | Insulin receptor-related protein | Rattus norvegicus (Rat) | SS |
P24062 | Igf1r | Insulin-like growth factor 1 receptor | Rattus norvegicus (Rat) | SS |
Q498D6 | Fgfr4 | Fibroblast growth factor receptor 4 | Rattus norvegicus (Rat) | PR |
P57097 | Mertk | Tyrosine-protein kinase Mer | Rattus norvegicus (Rat) | SS |
P97523 | Met | Hepatocyte growth factor receptor | Rattus norvegicus (Rat) | PR |
Q62956 | Erbb4 | Receptor tyrosine-protein kinase erbB-4 | Rattus norvegicus (Rat) | SS |
Q05030 | Pdgfrb | Platelet-derived growth factor receptor beta | Rattus norvegicus (Rat) | SS |
P20786 | Pdgfra | Platelet-derived growth factor receptor alpha | Rattus norvegicus (Rat) | SS |
P06494 | Erbb2 | Receptor tyrosine-protein kinase erbB-2 | Rattus norvegicus (Rat) | SS |
Q63474 | Ddr1 | Epithelial discoidin domain-containing receptor 1 | Rattus norvegicus (Rat) | SS |
P53767 | Flt1 | Vascular endothelial growth factor receptor 1 | Rattus norvegicus (Rat) | PR |
P15127 | Insr | Insulin receptor | Rattus norvegicus (Rat) | SS |
Q04589 | Fgfr1 | Fibroblast growth factor receptor 1 | Rattus norvegicus (Rat) | SS |
Q00495 | Csf1r | Macrophage colony-stimulating factor 1 receptor | Rattus norvegicus (Rat) | PR |
P55245 | EGFR | Epidermal growth factor receptor | Macaca mulatta (Rhesus macaque) | SS |
O16262 | nipi-4 | Protein nipi-4 | Caenorhabditis elegans | PR |
Q9LMN7 | WAK5 | Wall-associated receptor kinase 5 | Arabidopsis thaliana (Mouse-ear cress) | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MRATGTLQVL | CFLLSLARGS | EMGNSQAVCP | GTLNGLSVTG | DADNQYQTLY | KLYEKCEVVM |
70 | 80 | 90 | 100 | 110 | 120 |
GNLEIVLTGH | NADLSFLQWI | REVTGYVLVA | MNEFSVLPLP | NLRVVRGTQV | YDGKFAIFVM |
130 | 140 | 150 | 160 | 170 | 180 |
LNYNTNSSHA | LRQLKFTQLT | EILSGGVYIE | KNDKLCHMDT | IDWRDIVRVR | GAEIVVKNNG |
190 | 200 | 210 | 220 | 230 | 240 |
ANCPPCHEVC | KGRCWGPGPD | DCQILTKTIC | APQCNGRCFG | PNPNQCCHDE | CAGGCSGPQD |
250 | 260 | 270 | 280 | 290 | 300 |
TDCFACRRFN | DSGACVPRCP | EPLVYNKLTF | QLEPNPHTKY | QYGGVCVASC | PHNFVVDQTF |
310 | 320 | 330 | 340 | 350 | 360 |
CVRACPPDKM | EVDKHGLKMC | EPCGGLCPKA | CEGTGSGSRY | QTVDSSNIDG | FVNCTKILGN |
370 | 380 | 390 | 400 | 410 | 420 |
LDFLITGLNV | DPWHKIPALD | PEKLNVFRTV | REITGYLNIQ | SWPPHMHNFS | VFSNLTTIGG |
430 | 440 | 450 | 460 | 470 | 480 |
RSLYNRGFSL | LIMKNLNVTS | LGFRSLKEIS | AGRVYISANQ | QLCYHHSLNW | TRLLRGPSEE |
490 | 500 | 510 | 520 | 530 | 540 |
RLDIKYDRPL | GECLAEGKVC | DPLCSSGGCW | GPGPGQCLSC | RNYSREGVCV | THCNFLQGEP |
550 | 560 | 570 | 580 | 590 | 600 |
REFVHEAQCF | SCHPECLPME | GTSTCNGSGS | DACARCAHFR | DGPHCVNSCP | HGILGAKGPI |
610 | 620 | 630 | 640 | 650 | 660 |
YKYPDAQNEC | RPCHENCTQG | CNGPELQDCL | GQAEVLMSKP | HLVIAVTVGL | AVILMILGGS |
670 | 680 | 690 | 700 | 710 | 720 |
FLYWRGRRIQ | NKRAMRRYLE | RGESIEPLDP | SEKANKVLAR | IFKETELRKL | KVLGSGVFGT |
730 | 740 | 750 | 760 | 770 | 780 |
VHKGIWIPEG | ESIKIPVCIK | VIEDKSGRQS | FQAVTDHMLA | VGSLDHAHIV | RLLGLCPGSS |
790 | 800 | 810 | 820 | 830 | 840 |
LQLVTQYLPL | GSLLDHVKQH | RETLGPQLLL | NWGVQIAKGM | YYLEEHSMVH | RDLALRNVML |
850 | 860 | 870 | 880 | 890 | 900 |
KSPSQVQVAD | FGVADLLPPD | DKQLLHSEAK | TPIKWMALES | IHFGKYTHQS | DVWSYGVTVW |
910 | 920 | 930 | 940 | 950 | 960 |
ELMTFGAEPY | AGLRLAEIPD | LLEKGERLAQ | PQICTIDVYM | VMVKCWMIDE | NIRPTFKELA |
970 | 980 | 990 | 1000 | 1010 | 1020 |
NEFTRMARDP | PRYLVIKRAS | GPGTPPAAEP | SVLTTKELQE | AELEPELDLD | LDLEAEEEGL |
1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
ATSLGSALSL | PTGTLTRPRG | SQSLLSPSSG | YMPMNQSSLG | EACLDSAVLG | GREQFSRPIS |
1090 | 1100 | 1110 | 1120 | 1130 | 1140 |
LHPIPRGRPA | SESSEGHVTG | SEAELQEKVS | VCRSRSRSRS | PRPRGDSAYH | SQRHSLLTPV |
1150 | 1160 | 1170 | 1180 | 1190 | 1200 |
TPLSPPGLEE | EDGNGYVMPD | THLRGASSSR | EGTLSSVGLS | SVLGTEEEDE | DEEYEYMNRK |
1210 | 1220 | 1230 | 1240 | 1250 | 1260 |
RRGSPPRPPR | PGSLEELGYE | YMDVGSDLSA | SLGSTQSCPL | HPMAIVPSAG | TTPDEDYEYM |
1270 | 1280 | 1290 | 1300 | 1310 | 1320 |
NRRRGAGGAG | GDYAAMGACP | AAEQGYEEMR | AFQGPGHHAP | HVRYARLKTL | RSLEATDSAF |
1330 | |||||
DNPDYWHSRL | FPKANAQRT |